Simultaneous kinetic spectrophotometric determination of spironolactone and canrenone in urine using partial least-squares regressionMARTIN, E; JIMENEZ, A. I; HERNANDEZ, O et al.Talanta (Oxford). 1999, Vol 49, Num 1, pp 143-154, issn 0039-9140Article

EFFETS SEXUELS SECONDAIRES DE LA SPIRONOLACTONE: INTERET D'UNE THERAPEUTIQUE SUBSTITUTIVE PAR LA CANRENONEMARCO J; CONSTANS R; ALIBELLI MJ et al.1978; NOUV. PRESSE MED.; FRA; DA. 1978; VOL. 7; NO 40; PP. 3668; BIBL. 4 REF.Article

The negative inotropic action of canrenone is mediated by L-type calcium current blockade and reduced intracellular calcium transientsCOSTA, A. R; TORRES, L. B; TUCCI, Pjf et al.British journal of pharmacology. 2009, Vol 158, Num 2, pp 580-587, issn 0007-1188, 8 p.Article

Allergic contact dermatitis produced by canrenoneBLAYA, Bruno; GONZALEZ, Montserrat; RATON, Juan Antonio et al.Contact dermatitis. 2007, Vol 57, Num 3, issn 0105-1873, 197Article

Effects of canrenone in patients with metabolic syndromeDEROSA, Giuseppe; BONAVENTURA, Aldo; BIANCHI, Lucio et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 16, pp 2161-2169, issn 1465-6566, 9 p.Article

Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patientsSUYAGH, Maysa; HAWWA, Ahmed F; COLLIER, Paul S et al.British journal of clinical pharmacology. 2012, Vol 74, Num 5, pp 864-872, issn 0306-5251, 9 p.Article

RE-EVALUATION OF THE ANTIMINERALOCORTICOID EFFECT OF THE SPIRONOLACTONE METABOLITE, CANRENONE, FROM PLASMA CONCENTRATIONS DETERMINED BY A NEW HIGH-PRESSURE LIQUID CHROMATOGRAPHIC METHODDAHLOF CG; LUNDBORG P; PERSSON BA et al.1979; DRUG METABOL. DISPOSIT.; USA; DA. 1979; VOL. 7; NO 2; PP. 103-107; BIBL. 18 REF.Article

CANRENONE - THE PRINCIPAL ACTIVE METABOLITE OF SPIRONOLACTONE.RAMSAY LE; SHELTON JR; WILKINSON D et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; NO 4; PP. 607-612; BIBL. 20 REF.Article

THE METABOLISM OF CANRENONE IN VITRO BY RAT LIVER PREPARATIONSBOREHAM DR; VOSE CW; PALMIER RF et al.1981; XENOBIOTICA; ISSN 0049-8254; GBR; DA. 1981; VOL. 11; NO 4; PP. 231-240; BIBL. 20 REF.Article

SIMULTANEOUS AUTOMATED DETERMINATION OF SPIRONOLACTONE METABOLITES IN SERUM.NEUBERT P; KOCH K.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 8; PP. 1131-1134; BIBL. 6 REF.Article

SPIRONOLACTONE. I. DISPOSITION AND METABOLISMKARIM A; ZAGARELLA J; HRIBAR J et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 2; PP. 158-169; BIBL. 1 P. 1/2Article

APPRECIATION DE L'EFFET ANTI-HYPERTENSEUR DU CANRENONE PAR L'EPREUVE D'EFFORTYVENOU L; WITCHITZ S.1982; THERAPIE; ISSN 0040-5957; FRA; DA. 1982; VOL. 37; NO 5; PP. 595; BIBL. 4 REF.Article

EFFECT OF A SPIROLACTONE ON PLASMA AND URINARY ALDOSTERONE IN PRIMARY ALDOSTERONISM.VETTER H; APPENHEIMER M; LUCAS R et al.1977; HORMONE RES.; SWITZ.; DA. 1977; VOL. 8; NO 1; PP. 23-28; BIBL. 1 P.Article

SPIRONOLACTONE: RELATIONSHIP BETWEEN CONCENTRATIONS OF DETHIOACETYLATED METABOLITE IN HUMAN SERUM AND MILK.PHELPS DL; AZIZ KARIM.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 8; PP. 1203; BIBL. 10 REF.Article

INFLUENCE OF ACETYLSALICYLIC ACID ON THE RENAL HANDLING OF A SPIRONOLACTONE METABOLITE IN HEALTHY SUBJECTSRAMSAY LE; HARRISON IR; SHELTON JR et al.1976; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1976; VOL. 10; NO 1; PP. 43-48; BIBL. 20 REF.Article

The nitration of canrenone with acetic anhydride/nitric acidMEGGES, R; WEILAND, J; UNDEUTSCH, B et al.Steroids. 1997, Vol 62, Num 12, pp 762-766, issn 0039-128XArticle

Conventional and micellar liquid chromatography method development for danazol and validation in capsulesGONZALO-LUMBRERAS, R; IZQUIERDO-HORNILLOS, R.Journal of pharmaceutical and biomedical analysis. 2003, Vol 32, Num 3, pp 433-439, issn 0731-7085, 7 p.Article

A partial least-squares multivariate calibration method for the simultaneous spectrophotometric determination of spironolactone, canrenone and hydrochlorothiazideMARTIN, E; HERNANDEZ, O; JIMENEZ, A. I et al.Analytical letters. 1998, Vol 31, Num 11, pp 1857-1877, issn 0003-2719Article

ETUDE RANDOMISEE EN DOUBLE AVEUGLE DE L'EFFICACITE DU PHANURANE ET DE SA TOLERANCE CLINIQUE ET BIOLOGIQUE CHEZ L'HYPERTENDUFROMANTIN M.1979; SEM. HOP.; FRA; DA. 1979; VOL. 55; NO 41-42; PP. 1965-1967; ABS. ENG; BIBL. 2 REF.Article

SPIRONOLACTONE. II. BIOAVAILABILITYKARIM A; ZAGARELLA J; HUTSELL TC et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 2; PP. 170-176; BIBL. 12 REF.Article

THE EFFECT OF SPIRONOLACTONE AND CANRENONE ON THE DIGOXIN RADIOIMMUNOASSAY = INFLUENCE DE LA SPIRONOLACTONE ET DE LA CANRENONE SUR LE RADIOIMMUNODOSAGE DE LA DIGOXINEHUFFMAN DH.1974; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1974; VOL. 9; NO 4; PP. 787-790; BIBL. 1P.Article

Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cellsCALIGIURI, Alessandra; DE FRANCO, Raffaella M. S; GENTILINI, Paolo et al.Gastroenterology (New York, NY. 1943). 2003, Vol 124, Num 2, pp 504-520, issn 0016-5085, 17 p.Article

Development and validation of a dried blood spot: LC—APCI—MS assay for estimation of canrenone in paediatric samplesFAISAL SUYAGH, Maysa; PRASHANT LAXMAN, Kole; MILLERSHIP, Jeff et al.Journal of chromatography. B. 2010, Vol 878, Num 9-10, pp 769-776, issn 1570-0232, 8 p.Article

Bioequivalence Assessment of Two Formulations of Spironolactone in Chinese Healthy Male VolunteersXU, Feng-Guo; ZHANG, Zun-Jian; DONG, Hai-Juan et al.Arzneimittel-Forschung. 2008, Vol 58, Num 3, pp 117-121, issn 0004-4172, 5 p.Article

Antihypertensive therapy : Role of aldosterone antagonistsGRANDI, Anna Maria.Current pharmaceutical design. 2005, Vol 11, Num 17, pp 2235-2242, issn 1381-6128, 8 p.Article